Horizon Pharma To Buy Hyperion Therapeutics For $955.7 Million In A Cash And Debt Deal
March 30, 2015 at 18:24 PM EDT
The acquisition is designed to bolster the pipeline with two drugs that treat a rare disease. HZNP up 18.2%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
